• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

contract research organization

sold
Favicon Fierce Biotech

Charles River sells CDMO and discovery assets in strategic pivot

The CRO is offloading its contract manufacturing operation and some of its European discovery services, which brought in $287 million last year.
Darren Incorvaia Feb 25, 2026 1:54pm
graphic image of China flags overlapping with US flags

Senate backs China competition amendment in defense bill

Oct 10, 2025 10:56am
Abstract financial graph

WuXi Bio, WuXi XDC upbeat on 2025 after strong 2024 earnings

Mar 25, 2025 10:45am
sun storm cloudy clouds ominous horizon forecast

WuXi AppTec offers rosy 2025 guidance despite US-China tensions

Mar 18, 2025 4:30pm
mAb antibody monoclonal antibody

Syngene to pay $37M for Emergent's Baltimore biologics plant

Mar 10, 2025 3:45pm
China

BIOSECURE Act undermines confidence in Chinese partners: survey

Jul 2, 2024 1:42pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings